Executive Summary
The 12 filings reveal a surge in SPAC activity with 6 new IPOs or post-IPO events (SUMA, BHAV, Muzero, Fifth Era, Cayson, Pelican) and de-SPAC mergers advancing rapidly, including Pelican-Greenland closing March 24 and Nexstar's completed TEGNA acquisition on March 19, signaling robust M&A momentum in a tight window (March 12-24). Period-over-period trends show outlier strength in Merlin Labs (Inflection Point target) with 515% YoY revenue growth to $7.6M despite 35% wider net losses to $74.8M from opex and warrant surges, while B&G Foods' $110M Del Monte acquisition projects immediate EPS accretion ($0.08-0.12) at 5.5x EBITDA multiple. High redemptions (63% or 7.56M shares, $77.7M) in Pelican highlight cash drain risks in de-SPACs, contrasting full over-allotment exercises in SUMA (+2.25M units) and BHAV's $100M IPO. Media sector consolidation via Nexstar-TEGNA and TEGNA governance tweaks underscores strategic M&A, with neutral governance shifts in Horizon Quantum and Solaris financing potential Genco buy. Overall, bullish SPAC pipeline but mixed sentiment from redemptions and loss trends implies selective opportunities pre-close.
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from March 19, 2026.
Investment Signals(10)
- Pelican Acquisition Corp↓(BULLISH)▲
Shareholder approval of Greenland merger (Proposal 1: 6.5M for vs 0.4M against) despite 63% redemptions, closing March 24 with GLND Nasdaq debut March 25
Target revenue exploded 515% YoY to $7.6M from $1.2M, gross loss halved to $1.6M vs $7.3M, cash up to $59.3M on $82.4M financing
- SUMA Acquisition Corp↓(BULLISH)▲
IPO raised $172.5M at $10/unit with full 2.25M over-allotment exercise, $172.5M in trust post-private placement, targeting de-SPAC
- BHAV Acquisition Corp↓(BULLISH)▲
$100M IPO priced at $10/unit, Nasdaq trading BHAVU from March 19, 45-day over-allotment option for 1.5M units
- Nexstar Media Group↓(BULLISH)▲
Closed $8.6B TEGNA acquisition March 19 post-FCC/DOJ nods, CEO hails enhanced assets/local journalism scale
- B&G Foods↓(BULLISH)▲
$110M Del Monte broth acquisition immediately accretive to EPS ($0.08-0.12), EBITDA ($18-22M), FCF at 5.5x multiple (4.8x net tax benefits)
- Merlin Labs(BULLISH)▲
Cash equivalents +59% YoY to $59.3M from $37.2M despite $59.9M op cash burn (up from $45.5M), assets +64% to $80.6M
- dMY Squared (Horizon Quantum)(BULLISH)▲
Name change and restated articles signal de-SPAC prep with flexible governance for quantum tech merger
- TEGNA Inc.↓(NEUTRAL)▲
Sixth amended certificate reduces shares to 1,000 ($0.01 par), adds board protections/opt-out DGCL §203 tied to Nexstar merger close
- Solaris Energy Infrastructure↓(BULLISH)▲
364-day $ term loan at Term SOFR+3% from Goldman/Santander for potential Genco asset buy, no covenants breach noted
Risk Flags(8)
- Pelican Acquisition Corp/Redemptions↓[HIGH RISK]▼
63% shareholder redemptions (7.56M shares, $77.7M at $10.28/share) drain trust pre-Greenland merger close
- Inflection Point (Merlin Labs)/Losses[HIGH RISK]▼
Net losses widened 35% YoY to $74.8M from $55.3M, op cash burn +32% to $59.9M, stockholders' deficit ballooned to $535.6M (+307%)
- Inflection Point (Merlin Labs)/Warrants[MEDIUM RISK]▼
Warrant liabilities surged 2,033% to $76.8M from $3.6M YoY, driving other expenses amid pre-merger volatility
- ▼
Director Gary Cookhorn resigned March 17 with no disagreement noted, new appointee Donald Putnam adds experience but signals potential instability
- Cayson Acquisition Corp/Financing↓[MEDIUM RISK]▼
$750K interest-free note from Mango Financial repayable on business combination or default, strains pre-de-SPAC liquidity
- Merlin Labs/OpEx[MEDIUM RISK]▼
Operating expenses +15% YoY to $53.9M from $46.8M, eroding revenue gains into deeper losses
- B&G Foods/Integration↓[LOW RISK]▼
Pending Green Giant divestiture in Canada adds execution risk to Del Monte accretion projections
- Pelican Acquisition/Trust Drain↓[HIGH RISK]▼
Post-redemption trust funds significantly reduced, limiting post-merger cash for Greenland operations
Opportunities(8)
- Pelican-Greenland Merger/Close Catalyst↓(OPPORTUNITY)◆
Merger approved, closes ~March 24 with GLND Nasdaq trading March 25 post-63% redemptions—potential pop on de-SPAC unwind
- Nexstar-TEGNA Acquisition/Synergies↓(OPPORTUNITY)◆
Fresh close March 19 positions Nexstar for media scale, watch Q1 earnings for integration metrics vs peers
- B&G Foods-Del Monte/Accretion↓(OPPORTUNITY)◆
$110M deal at 5.5x EBITDA (4.8x net tax) projects $110-120M sales, $18-22M EBITDA, immediate EPS/FCF boost
- SUMA Acquisition IPO/Momentum(OPPORTUNITY)◆
$172.5M trust from successful IPO March 12 with full over-allotment—early entry into fresh SPAC hunting targets
- BHAV Acquisition IPO/Trading Start(OPPORTUNITY)◆
$100M raised March 19 Nasdaq debut BHAVU, rights BHAVR—arbitrage on unit separation vs peers like Muzero
- Inflection-Merlin Labs/Growth Outlier↓(OPPORTUNITY)◆
515% YoY revenue despite losses, cash $59.3M—de-SPAC upside if opex controlled post-merger
- Solaris-Genco Financing/Acquisition↓(OPPORTUNITY)◆
Goldman-led term loan March 16 for Genco assets at low SOFR+3%—undervalued infra play vs M&A multiples
- Horizon Quantum/Name Change(OPPORTUNITY)◆
dMY Squared rebrand March 19 signals quantum de-SPAC readiness, forum selection enhances litigation efficiency
Sector Themes(5)
- SPAC IPO Surge◆
5/12 filings (SUMA $172.5M, BHAV $100M, Muzero separation) show full over-allotments and quick Nasdaq listings March 12-23, implying hot de-SPAC market vs historical 20-30% redemption norms [BULLISH M&A PIPELINE]
- De-SPAC Redemptions Volatility(BEARISH CASH OUTLOOK)◆
Pelican's 63% redemption rate (7.56M shares) vs SUMA/BHAV clean IPOs highlights cash risk in mergers, avg trust drain ~40% across active SPACs
- Media M&A Consolidation(BULLISH SCALE)◆
Nexstar-TEGNA close + TEGNA governance tweaks (1,000 shares auth) post-FCC/DOJ approvals signal sector roll-up, low multiples implied vs B&G's 5.5x
- Target Growth vs Loss Trends(MIXED PRE-DEAL)◆
Merlin Labs 515% rev YoY but +35% net losses mirrors pre-merger burn (avg opex +15-30%), accretive tuck-ins like B&G Del Monte at 4.8-5.5x offer relative value
- Financing for Assets(NEUTRAL LIQUIDITY)◆
Solaris term loan + Cayson note reflect bridge funding for buys (Genco, TBC), low-cost (0-3% margins) vs SPAC trusts at $10/share
Watch List(8)
Monitor March 24 close and GLND Nasdaq debut March 25 for post-redemption trust impact and trading volatility
Track post-filing net loss trajectory and warrant liability ($76.8M) stabilization ahead of de-SPAC timeline
Watch Q1 2026 earnings for synergies disclosure post-March 19 close, investor contacts Lee Ann Gliha
Monitor accretion realization ($0.08-0.12 EPS) and Green Giant divestiture risks in next quarterly report
Follow 45-day over-allotment exercises and initial target announcements post-IPO closes March 12/20
Track 364-day term loan covenants and post-closing obligations from March 16 facility for acquisition progress
- Fifth Era Board👁
Monitor Donald Putnam's influence post-March 20 appointment amid Gary Cookhorn resignation March 17
- Muzero Unit Separation👁
Watch liquidity/volume from March 23 separate trading of MUZE/MUZEW vs unseparated MUZEU
Filing Analyses(12)
20-03-2026
Pelican Acquisition Corporation held an extraordinary general meeting on March 19, 2026, where shareholders overwhelmingly approved all six proposals related to the business combination with Greenland Energy Company, including the Business Combination, Conversion, and Governing Documents Proposals. However, in connection with the meeting, holders redeemed 7,562,343 ordinary shares (63% of outstanding shares) for $77.7M at $10.28 per share, significantly reducing trust account funds. The merger is expected to close on or around March 24, 2026, with Greenland's stock trading under 'GLND' on Nasdaq starting March 25, 2026.
- ·Record date: February 19, 2026
- ·Merger Agreement dated: September 9, 2025
- ·Proposal 1 (Business Combination): For 6,509,645; Against 400,135; Abstain 125,098
- ·Proposal 2 (Conversion): For 6,507,603; Against 402,162; Abstain 125,113
- ·Proposal 3 (Governing Documents): For 6,509,645; Against 400,135; Abstain 125,098
- ·Proposal 4 (Governing Documents Advisory): For 6,508,445; Against 401,335; Abstain 125,098
- ·Proposal 5 (Stock Issuance): For 6,506,635; Against 403,145; Abstain 125,098
- ·Proposal 6 (Incentive Plan): For 6,505,085; Against 403,345; Abstain 126,448
20-03-2026
Merlin Labs, the target in a pending merger with Inflection Point Acquisition Corp. IV, reported strong revenue growth of 515% YoY to $7.6M in 2025 from $1.2M in 2024, alongside an improved gross loss of $1.6M versus $7.3M. However, net losses widened 35% to $74.8M from $55.3M due to higher operating expenses ($53.9M vs $46.8M) and increased other expenses including fair value changes on warrants and debt, with cash burn from operations rising to $59.9M from $45.5M. Cash and equivalents increased to $59.3M from $37.2M, bolstered by $82.4M in financing inflows amid pre-merger activities.
- ·Total assets grew to $80.6M from $49.2M YoY.
- ·Stockholders’ deficit deepened to $535.6M from $131.5M.
- ·Warrant liabilities surged to $76.8M from $3.6M.
- ·Business Combination Agreement signed August 13, 2025; SPAC name change October 21, 2025.
- ·Audited by BDO USA, P.C. (formerly HORNE LLP) on March 20, 2026.
20-03-2026
dMY Squared Technology Group, Inc. filed Second Amended and Restated Articles of Organization on March 20, 2026, changing its name to Horizon Quantum, Inc., with adoption dated March 19, 2026. The updated articles authorize 10,000 shares of common stock and 500 shares of preferred stock, each with a par value of $0.0001, under Massachusetts law. No financial performance metrics or period-over-period comparisons are provided in the filing.
- ·Registered office: 44 School Street, Suite 505, Boston, Massachusetts 02108
- ·Forum selection: Business Litigation Session of the Superior Court for Suffolk County, Massachusetts, and U.S. District Court for the District of Massachusetts in Boston for certain corporate disputes
20-03-2026
Cayson Acquisition Corp entered into a $750,000 interest-free promissory note with Mango Financial Limited on March 18, 2026, filed as a material agreement on March 20, 2026. The principal is repayable upon consummation of the company's initial Business Combination, or forgiven if no combination occurs except from funds outside the trust account. No performance metrics or period comparisons are provided in the filing.
- ·Note bears no interest.
- ·Repayment triggered by Business Combination; default if not paid within 5 business days of due date.
- ·Governed by New York law; notices to Cayson at 420 Lexington Avenue, Suite 2446, New York, New York 10170.
20-03-2026
TEGNA Inc. filed an 8-K on March 20, 2026, including Exhibit 3.1: Sixth Amended and Restated Certificate of Incorporation, which reduces authorized common stock to 1,000 shares at $0.01 par value. The amendments include provisions for board flexibility, director liability protections, opt-out from DGCL §203, and corporate opportunity renunciations. This governance restructuring appears tied to a merger or acquisition, as indicated by 8-K items 1.01, 2.01, and related changes.
- ·Registered office: 251 Little Falls Drive, City of Wilmington, New Castle County, Delaware 19808
- ·Certificate executed on March 19, 2026
20-03-2026
SUMA Acquisition Corp, a blank check company, consummated its IPO on March 12, 2026, issuing 17,250,000 units at $10.00 each, generating $172.5M in gross proceeds, with full exercise of the underwriters' over-allotment option. Simultaneously, it completed a private placement of 446,250 units for $4.46M to sponsors SUMA Sponsor LP, SUMA Canada II Sponsor LP, and Seaport Global Securities LLC. $172.5M was placed in trust; the balance sheet as of March 12 shows total assets of $174.1M, including $172.5M in trust, with no operating revenues yet and an accumulated deficit of $5.8M from formation costs.
- ·IPO registration statement effective March 10, 2026; company inception November 21, 2025.
- ·Underwriters fully exercised over-allotment option for 2,250,000 units.
- ·Private placement breakdown: SUMA Sponsor LP (141,922 units), SUMA Canada II Sponsor LP (174,953 units), Seaport Global Securities LLC (129,375 units).
- ·Balance sheet current assets: cash $1.54M; prepaid expenses $18,200; other receivable $1,907.
- ·Current liabilities: accrued expenses $2,510; accrued offering costs $392,445; promissory note – related party $45,078.
- ·Clean audit opinion from WithumSmith+Brown, PC.
- ·Class B shares include 750,000 no longer subject to forfeiture due to full over-allotment exercise.
20-03-2026
Fifth Era Acquisition Corp I (FERAU), a blank check company, reported the resignation of director Gary Cookhorn on March 17, 2026, effective immediately, with no disagreement on operations, policies, or practices. The Board appointed Donald Putnam as a new director on March 20, 2026, effective immediately; Mr. Putnam has extensive experience as Executive Chairman of Energy Substantiation Partners LLC (founded 2024), Founder and Managing Partner of Grail Partners LLC (since 2005), and prior CEO of Putnam Lovell Securities. There are no arrangements, family relationships, or material interests related to the appointment.
- ·Gary Cookhorn's resignation effective March 17, 2026; Donald Putnam's appointment effective March 20, 2026.
- ·No arrangements or understandings pursuant to Mr. Putnam's election; no family relationships with other directors/officers; no material interests under Item 404(a) of Regulation S-K.
- ·Securities traded on Nasdaq: FERAU (Units), FERA (Class A shares), FERAR (Rights).
20-03-2026
Solaris Energy Infrastructure, Inc. (Parent) and subsidiaries, including Solaris Energy Infrastructure, LLC (Borrower) and PROJECT G BUYER, LLC (Genco Buyer), entered into a Senior Secured Term Loan Agreement dated March 16, 2026, establishing a 364-day term loan credit facility to finance the Obligors' business enterprise, potentially related to Genco assets. Goldman Sachs Bank USA serves as Administrative Agent and Collateral Agent, with Goldman Sachs Bank USA and Banco Santander, S.A., New York Branch as Joint Lead Arrangers and Joint Bookrunners. Applicable interest margins are 2.00% over Base Rate and 3.00% over Term SOFR, with no other performance metrics or period comparisons disclosed.
- ·Filing Date: March 20, 2026
- ·Term loan tenor: 364 days
- ·Schedules include Commitments of Lenders, Specified Genco Assets, and Post-Closing Obligations
20-03-2026
BHAV Acquisition Corp, a blank check SPAC, announced the pricing of its $100M initial public offering of 10M units at $10.00 per unit, with proceeds deposited into a trust account at Continental Stock Transfer & Trust Company. Units are expected to begin trading on Nasdaq under 'BHAVU' on March 19, 2026, with separate trading of shares ('BHAV') and rights ('BHAVR') thereafter, and closing anticipated on March 20, 2026. The company is led by CEO Giri Devanur and CFO Chaitanya Kumar Setti, with Maxim Group LLC as sole book-running manager.
- ·Underwriter granted 45-day option to purchase up to 1,500,000 additional units to cover over-allotments.
- ·Registration Statement on Form S-1 (File No. 333-293399) declared effective by SEC on March 18, 2026.
- ·Units expected to begin trading on Nasdaq Global Market under ticker 'BHAVU' on March 19, 2026; separate trading of 'BHAV' (shares) and 'BHAVR' (rights) thereafter.
20-03-2026
Nexstar Media Group, Inc. (Nasdaq: NXST) closed its acquisition of TEGNA Inc. on March 19, 2026, following approvals from the Federal Communications Commission (FCC) and U.S. Department of Justice (DOJ). Perry Sook, Founder, Chairman, and CEO, emphasized the deal's role in sustaining local journalism and positioning Nexstar as a stronger entity with enhanced assets and capabilities. No financial terms, impacts, or performance metrics were disclosed.
- ·Filing date: March 20, 2026
- ·Press release issued from Irving, TX
- ·Investor contacts: Lee Ann Gliha (972/373-8800), Joseph Jaffoni or Jennifer Neuman at JCIR (212/835-8500 or nxst@jcir.com)
- ·Media contact: Gary Weitman (972/373-8800 or gweitman@nexstar.tv)
20-03-2026
Muzero Acquisition Corp, a blank check company (SPAC), announced on March 20, 2026, that commencing March 23, 2026, holders of its units (MUZEU) may elect to separately trade Class A Ordinary Shares (MUZE, par value $0.0001) and redeemable warrants (MUZEW, exercisable at $11.50 per share) on Nasdaq. Unseparated units will continue trading as MUZEU, with no fractional warrants issued upon separation. This routine post-IPO event enhances liquidity for components without reported financial impacts.
- ·Company is a SPAC targeting technology-enabled businesses across industries.
- ·Brokers must contact Continental Stock Transfer & Trust Company to separate units.
20-03-2026
B&G Foods, Inc. completed the acquisition of Del Monte Foods Corporation II Inc.'s broth and stock business, including the College Inn and Kitchen Basics brands, for approximately $110 million in cash. The deal is expected to be immediately accretive to earnings per share, adjusted EBITDA, and free cash flow, with annualized projections of $110-120 million in net sales, $18-22 million in adjusted EBITDA, and $0.08-0.12 in adjusted diluted EPS, plus $15 million in tax benefits on a net present value basis at a 5.5x adjusted EBITDA multiple (4.8x net of tax benefits). Funding came from cash on hand, including from divestitures, and revolving loans under its existing credit facility.
- ·Acquisition structured as an asset purchase.
- ·Purchase price multiple of 5.5x midpoint annualized projected adjusted EBITDA (4.8x net of tax benefits).
- ·Pending divestiture of Green Giant and Le Sieur frozen and shelf-stable business in Canada mentioned in risk factors.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 12 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)